NewBridge Pharmaceuticals -2018 winner of the Most Innovative Pharmaceutics Commercialisation Partner MENA award

“The www.CFI.co judging panel applauds the company’s mission to address unmet medical needs in the MENA region through strategic joint-ventures and partnerships, naming NewBridge Pharmaceuticals the 2018 winner of the…

NewBridge Pharmaceuticals at WCO-IOF-ESCEO Paris 2019

Joe Henein, the President & CEO of NewBridge Pharmaceuticals, Sherif Hamdy Franchise Head Metabolic Care and Lina Sabbagh Commercial Lead CNS Lebanon attended the World Congress on Osteoporosis, Osteoarthritis and…

NewBridge Pharmaceuticals at EASL 2019

NewBridge President and CEO Joe Henein, Business Director Group Franchise Hisham EL Sayed and Brand Manager Rare Diseases Jennifer Bteich, attended The International Liver Congress “EASL 2019”, that was held…

Multiple Products, Multiple Geographies

TBY talks to Joe Henein, CEO of NewBridge Pharmaceuticals, on building brands, supporting SMEs in the region, and driving innovation. To read more, click on this link. Source Article: thebusinessyear…

First CPhI Middle East & Africa 2018 concludes in Abu Dhabi

On day 2 of CPhI Middle East & Africa 2018,  Joe Henein, CEO, NewBridge Pharmaceuticals delivered a session identifying the “Key challenges to bringing innovations to market”. Source Link:  Zawya…

NewBridge Pharmaceuticals attending the ASCO Annual Meeting 2018

NewBridge Pharmaceuticals team will  attend the American Society of  Clinical Oncology – ASCO Annual Meeting 2018 (1st to 5th of June, 2018) in Chicago headed by Chief Executive Officer, Joe…

12th International Pharmaceutical and Medical Device Compliance Congress

Joe Henein, President & CEO, NewBridge Pharmaceuticals is attending the 12th International Pharmaceutical and Medical Device Compliance Congress from 14th to 16th May, 2018 in Vienna, Austria.   Joe – as…

REACHING NEW HEIGHTS

 TBY talks to Joe W. Henein, CEO & President of NewBridge Pharmaceuticals, on the importance of increased access to medicine in the region, role of SME’s high-end specialty pharmaceutical services,…

Ever Wider Access

TBY talks to Joe W. Henein, President & CEO of NewBridge Pharmaceuticals, on the attractivenss of the MENA region to pharmaceuticals firms and the trends driving growth in the UAE…

Sunovion Pharmaceuticals Europe Ltd. and NewBridge Pharmaceuticals Announce Agreement for Distribution of Latuda® (lurasidone) in the Gulf Cooperation Council Region

Sunovion Pharmaceuticals Europe Ltd. (Sunovion) and NewBridge Pharmaceuticals (NewBridge) have signed a distribution agreement to make Latuda® (lurasidone), an atypical antipsychotic, available in the six countries of the Gulf Cooperation…